PPIA Knockout NALM6, clone G5 Cell Line

The choice depends on whether you are studying PPIA (cyclophilin A, CypA)'s role as a peptidyl-prolyl cis-trans isomerase or its functions in HIV-1 replication, immune signaling, and B-cell biology. The Knockout line is the standard tool for asking whether CypA is required for these processes — CypA is the most abundant cyclophilin, with documented roles in HIV-1 capsid uncoating, protein folding, and as a target of cyclosporin A immunosuppression. Overexpression is useful for studying CypA in heterologous expression contexts. For B-cell and HIV research, the EDITGENE PPIA Knockout in NALM6 (clone G5) is highly relevant — NALM6 is a human B-cell precursor acute lymphoblastic leukemia (B-ALL) line, and CypA plays critical roles in lymphocyte biology and HIV-1 cyclophilin-capsid interactions. Rescue with wild-type or catalytically-dead (R55A) CypA enables structure-function studies. The knockout is a critical specificity control for cyclosporin A immunosuppressive mechanism — CsA-CypA complex inhibits calcineurin. The NALM6 background is particularly valuable for B-cell-relevant CypA function studies.

Primary applications: • Cyclosporin A immunosuppression mechanism: critical genetic control for cyclosporin A — CsA-CypA complex inhibits calcineurin in B-cell precursor leukemia context. • HIV-1 capsid uncoating: studies of HIV-1 infection in CypA-deficient B-cell lineage cells given CypA's role in capsid uncoating. • Peptidyl-prolyl isomerase substrate analysis: in vitro PPIase activity assays and structural folding studies of candidate substrates. • B-cell biology: NALM6 is a B-ALL line, enabling B-cell-relevant CypA function studies. EDITGENE recommends this model for researchers investigating cyclophilin biology in B-cell lineage and lymphoid cancer contexts. The NALM6 clone G5 background is suitable for B-ALL drug response and cyclosporin A mechanism studies.

Yes. CypA rescue experiments are well-established for cyclophilin research: • Construct design: use a codon-modified PPIA sequence with a small C- or N-terminal tag (FLAG, HA). CypA is small (~165 aa) cyclosolic protein — both tag positions are typically tolerated. • Catalytically-dead rescue: the R55A mutation in the active site abolishes peptidyl-prolyl isomerase activity and is the standard specificity control. • CsA-binding-deficient rescue: specific mutations in the cyclosporin A binding pocket enable distinguishing CsA-dependent from PPIase-independent functions. • Functional readout: rescue should restore PPIase activity (in vitro substrate folding) and CsA sensitivity in calcineurin inhibition assays. NALM6 (clone G5) is a B-ALL cell line — lentiviral transduction of suspension B-lymphoid cells may require optimization (spinoculation, polybrene); flow cytometry-based clone selection is standard practice.